Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthetic Approaches, Biological Activities, and Structure–Activity Relationship of Pyrazolines and Related Derivatives
Rajnish Kumar, Himanshu Singh, Avijit Mazumder, et al.
Topics in Current Chemistry (2023) Vol. 381, Iss. 3
Closed Access | Times Cited: 16

Showing 16 citing articles:

Coumarin hybrids for targeted therapies: A promising approach for potential drug candidates
Nameer Mazin Zeki, Yasser Fakri Mustafa
Phytochemistry Letters (2024) Vol. 60, pp. 117-133
Closed Access | Times Cited: 20
Natural linear coumarin-heterocyclic conjugates: A review of their roles in phytotherapy
Nameer Mazin Zeki, Yasser Fakri Mustafa
Fitoterapia (2024) Vol. 175, pp. 105929-105929
Closed Access | Times Cited: 13
Synthesis and evaluation of novel ring-conjugated coumarins as biosafe broad-spectrum antimicrobial candidates
Nameer Mazin Zeki, Yasser Fakri Mustafa
Journal of Molecular Structure (2024) Vol. 1309, pp. 138192-138192
Closed Access | Times Cited: 12
Novel heterocyclic coumarin annulates: synthesis and figuring their roles in biomedicine, bench-to-bedside investigation
Nameer Mazin Zeki, Yasser Fakri Mustafa
Chemical Papers (2024) Vol. 78, Iss. 8, pp. 4935-4951
Closed Access | Times Cited: 12
Coumarin hybrids: a sighting of their roles in drug targeting
Nameer Mazin Zeki, Yasser Fakri Mustafa
Chemical Papers (2024) Vol. 78, Iss. 10, pp. 5753-5772
Closed Access | Times Cited: 10
Exploring novel pyrazole-nitroimidazole hybrids: Synthesis and antiprotozoal activity against the human pathogen trichomonas vaginalis
Rafaela Corrêa Silva, Anna De Freitas, Bruno Vicente, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 102, pp. 117679-117679
Closed Access | Times Cited: 4
Discovery of 2-Pyrazolines That Inhibit the Phosphorylation of STAT3 as Nanomolar Cytotoxic Agents
Tejaswini P. Siddappa, Akshay Ravish, Xi Zhang, et al.
ACS Omega (2025) Vol. 10, Iss. 1, pp. 114-126
Open Access
Exploring pyrazolines as potential inhibitors of NSP3-macrodomain of SARS-CoV-2: synthesis and in silico analysis
R. R. Joshi, Harsh Gaikwad, Bhavana Soge, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nitrogen, Oxygen, and Sulphur Heterocycles as Potent Anti‐Inflammatory Agents: Insight Into the Synthetic Routes
Mariam Khadri, Uday Shashikumar, Pei‐Chien Tsai, et al.
ChemistrySelect (2025) Vol. 10, Iss. 9
Closed Access
Annulated Heterocyclic[g]Coumarin Composites: Synthetic Approaches and Bioactive Profiling
Nameer Mazin Zeki, Yasser Fakri Mustafa
Chemistry & Biodiversity (2023) Vol. 21, Iss. 3
Closed Access | Times Cited: 10
Synthesis of Novel Dioxathiole-6,7-coumarin Hybrids As Cytosafe-Multifunctional Applicants: An In Vitro—In Silico Study
Nameer Mazin Zeki, Yasser Fakri Mustafa
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 5, pp. 2076-2091
Closed Access | Times Cited: 3
Catalytic enantioselective synthesis of 2-pyrazolines via one-pot condensation/6π-electrocyclization: 3,5-bis(pentafluorosulfanyl)-phenylthioureas as powerful hydrogen bond donors
Moises A. Romero Reyes, Subhradeep Dutta, Minami Odagi, et al.
Chemical Science (2024) Vol. 15, Iss. 37, pp. 15456-15462
Open Access | Times Cited: 1
Synthesis, In vivo, and In silico Evaluation of New Pyrazoline‐Benzothiazole Conjugates as Antiepileptic Agents
Himanshu Singh, Rajnish Kumar, Avijit Mazumder, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 8
Closed Access | Times Cited: 1
New pyridine‐based chalcones and pyrazolines with anticancer, antibacterial, and antiplasmodial activities
Jonathan Ramírez–Prada, Juan S. Rocha‐Ortiz, Marta I. Orozco, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 7
Closed Access
From Isoniazid to 2-Pyrazolines: Synthesis, In silico Behaviour and Antimicrobial Activity
Geetha Birudala, Gurinderdeep Singh, S. Abdur Rahman Junaid Nayeem, et al.
Asian Journal of Chemistry (2024) Vol. 36, Iss. 8, pp. 1812-1820
Open Access
Medicinal Attributes of Pyrazoline in Drug Discovery
Disha Arora, Jyoti Singh, Sandeep Kumar
Letters in Drug Design & Discovery (2023) Vol. 21, Iss. 14, pp. 2811-2827
Closed Access
Page 1

Scroll to top